Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 5 - Biological Sciences
- Output identifier
- 26
- Type
- D - Journal article
- DOI
-
10.1038/s41591-018-0009-7
- Title of journal
- Nat Med
- Article number
- -
- First page
- 628
- Volume
- 24
- Issue
- 5
- ISSN
- 1546-170X
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
https://www.nature.com/articles/s41591-018-0009-7#Sec19
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
37
- Research group(s)
-
-
- Citation count
- 237
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -